Dana Taylor


Authored Items

A New Prior Authorization Decision-Support Tool Can Reduce the Costs of Cancer Treatment

August 2017, Vol 7, No 8 - Reimbursement

Unless the costs of cancer care are reduced significantly, it is estimated that by 2028, the combination of patients’ health insurance premium costs plus out-of-pocket expenses will be the same as the average US household income. Cancer drug costs are escalating at an even faster rate, at least in part because of accelerated new approvals by the FDA and higher drug unit costs. [ Read More ]